Tag: Stock pick

  • Dalrymple Bay Infrastructure shares: terminal update and capacity outlook

    A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements

    The Dalrymple Bay Infrastructure Ltd (ASX: DBI) share price is in focus after the company provided an update during its Dalrymple Bay Terminal site visit, highlighting the terminal’s fully contracted volume of 84.2 million tonnes per annum (Mtpa) to 2028 and continued strong demand for metallurgical coal exports.

    What did Dalrymple Bay Infrastructure report?

    • Dalrymple Bay Terminal is fully contracted to its 84.2Mtpa capacity through to June 2028 under take-or-pay agreements
    • About 81% of revenue derives from predominantly metallurgical coal mines, with DBT supplying 14% of global seaborne met coal exports in 2024
    • The terminal shipped coal to 22 countries from 21 mines owned by 11 major customers in the year to 31 December 2024
    • DBI has successfully delivered over $430 million in non-expansion capital expenditure (NECAP) projects since 2008
    • Ongoing NECAP works are forecast at $30 million to $50 million per annum, with a strong alignment between customers and operator

    What else do investors need to know?

    Dalrymple Bay Infrastructure’s revenue is underpinned by long-term take-or-pay contracts, which lowers volume risk and supports predictable cash flows. The terminal plays a strategic role in the global steelmaking supply chain, handling a significant portion of Australia’s metallurgical coal exports from the Bowen Basin.

    The company retains a 75-year lease on the terminal, with the operator owned by a subset of customers managing day-to-day activities. This structure is designed to minimise operational complexity and risk for DBI while aligning investment decisions with customer needs.

    What’s next for Dalrymple Bay Infrastructure?

    Looking ahead, Dalrymple Bay Infrastructure is planning for the 8X expansion, which could increase terminal capacity to 99.1Mtpa. All primary environmental approvals for the expansion have already been secured, and DBI is consulting with customers about next steps.

    The company is also exploring a range of funding options—beyond the traditional debt and equity mix—to deliver growth, while maintaining its focus on stable distributions to securityholders. Core sustaining capital works are expected to remain a priority, ensuring long-term operational reliability and customer satisfaction.

    Dalrymple Bay Infrastructure share price snapshot

    Over the past 12 months, Dalrymple Bay Infrastructure shares have risen 28%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has increased 1% over the same period.

    View Original Announcement

    The post Dalrymple Bay Infrastructure shares: terminal update and capacity outlook appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Dalrymple Bay Infrastructure Limited right now?

    Before you buy Dalrymple Bay Infrastructure Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Dalrymple Bay Infrastructure Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Here’s the earnings forecast out to 2030 for NAB shares

    A man in a suit smiles at the yellow piggy bank he holds in his hand.

    Owners of National Australia Bank Ltd (ASX: NAB) shares recently saw their bank report the FY25 result. Earnings didn’t quite go in the right direction.

    NAB reported that cash earnings declined by 0.2% to $7.09 billion, despite gross loans and advances (GLA) climbing by 5.9%.

    Expenses climbed 4.6%, faster than revenue growth, which included $130 million related to the payroll review and remediation charges.

    Excluding payroll review and remediation charges, expenses increased by 3.2%, reflecting higher personnel and technology-related costs, partially offset by productivity benefits. The bank said that underlying net profit rose 1.3% in FY25.

    In terms of the credit impairment, it said that the charge was $833 million in FY25, compared to $728 million in FY24. However, the overall percentage of non-performing loans increased again to 1.55%, up from 1.39% in FY24 and 1.13% in FY23.

    After seeing those numbers, let’s check out what experts think could happen with earnings in the coming years,

    FY26

    UBS decided to decrease its earnings per share (EPS) forecasts by between 3% and 4.8% over the financial years of FY26, FY27, and FY28 due to costs and credit charges. Earnings are usually a key driver of the NAB share price.

    The broker gave the following commentary on the outlook for the largest business lender:

    The investment case for NAB is straightforward, as the bank is not pursuing a significant or costly transformation plan or self-improvement initiatives (unlike peers such as Westpac Banking Corp (ASX: WBC) and ANZ Group Holdings Ltd (ASX: ANZ) ). NAB benefits from stability in senior leadership and a consistent strategy.

    However, its recent performance falls short of expectations. Returns in 2H 25 have declined to their lowest levels since COVID, at 63bps on AA. If NAB continues to deliver similar results, shareholder pressure is likely to increase. To drive earnings growth, the bank must focus on rebuilding capital buffers, maintaining cost discipline, and executing targeted lending growth initiatives.

    Putting all of that together, UBS is currently forecasting that NAB could achieve a net profit of $7.05 billion in FY26, which would be virtually flat compared to FY25.

    FY27

    The broker UBS thinks the bottom line of the ASX bank share could improve by around $200 million in the 2027 financial year.

    UBS projects a net profit of $7.2 billion in FY27.

    FY28

    The net profit could improve again in FY28 if the broker’s projections prove accurate.

    UBS predict that NAB’s net profit could climb to $7.6 billion in the 2028 financial year.

    FY29

    Currently, the projection from UBS experts suggests that NAB’s profit could increase by around $600 million to $8.2 billion in FY29.

    FY30

    The final financial year of these forecasts could be the best of all for owners of NAB shares.

    UBS predicts that the ASX bank share could generate $8.7 billion of net profit in the 2030 financial year. That would imply a potential 23.8% increase in profit between FY26 and FY30.

    In my view, that’d be a useful tailwind for the NAB share price, though that’s not a huge rise over five years.

    Other ASX shares may be capable of stronger returns.

    The post Here’s the earnings forecast out to 2030 for NAB shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in National Australia Bank Limited right now?

    Before you buy National Australia Bank Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and National Australia Bank Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • A2 Milk shares slip despite guidance upgrade

    Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.

    A2 Milk Company Ltd (ASX: A2M) shares are on the slide on Thursday.

    In morning trade, the infant formula company’s shares are down over 4% to $8.78.

    Why are A2 Milk shares falling?

    The catalyst for today’s decline has been the release of a trading update ahead of its annual general meeting.

    According to the release, the infant milk formula (IMF), other nutritionals and liquid milk product categories have been trading stronger than expected during the first half of FY 2026. However, it is possible that the market was already factoring this in and possibly even more.

    Commenting on its performance so far in FY 2026, A2 Milk’s CEO, David Bortolussi, said:

    I’m pleased to say that we’ve started the financial year strongly with IMF, Other Nutritionals and Liquid Milk product categories all trading ahead of expectations. In addition, changes to actual and forecast currency rates reflecting NZD depreciation are expected to inflate sales and expenses, with the impact to EBITDA not expected to be material.

    In light of this, the company has upgraded its guidance for the year ahead.

    On a continuing operations basis, A2 Milk now expects low double-digit percentage revenue growth in FY 2026. Previously it was guiding to high single-digit percentage growth from its continuing operations.

    Management notes that first half revenue growth in FY 2026 is expected to be higher than second half revenue growth. In addition, English label IMF revenue growth is expected to be significantly higher than China label IMF revenue growth.

    Management also reaffirmed its EBITDA margin guidance. It continues to expect an EBITDA margin in the range of approximately 15% to 16% for the year. Its depreciation and amortisation guidance has also been reaffirmed at approximately NZ$20 million to NZ$24 million.

    One item heading in the wrong direction is A2 Milk’s capital expenditure guidance, which has been lifted by NZ$10 million to NZ$60 million to NZ$80 million. This reflects the accelerated progress of the a2 Pokeno capital investment programme.

    And finally, net profit after tax is expected to be “slightly up” on what was delivered in FY 2025. This compares to its previous guidance for a relatively flat net profit.

    Special dividend

    At the event, Bortolussi reaffirmed the company’s plan to reward shareholders with a fully franked NZ$300 million special dividend. He said:

    As noted by our Chair in her address, the Board intends to declare a special dividend of $300 million, subject to obtaining regulatory approvals, to bring the new China label registered products under the a2MC brand, which is expected to take up to twelve months from when we announced the acquisition. The special dividend is expected to be unimputed and fully franked.

    The post A2 Milk shares slip despite guidance upgrade appeared first on The Motley Fool Australia.

    Should you invest $1,000 in The a2 Milk Company Limited right now?

    Before you buy The a2 Milk Company Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and The a2 Milk Company Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • DroneShield directors’ share sales and contract error: What investors need to know

    A hip young man with a beard and manbun sits thoughtfully at his laptop computer in a darkened room, staring at the screen with his chin resting on his hand in thought.

    The DroneShield Ltd (ASX: DRO) share price has been in the spotlight following a series of director share sales and a retraction of a previously announced contract win. Key recent developments include director disposals of more than 19.9 million shares and an error in recognising orders as “new,” later corrected by the company.

    What did DroneShield report today?

    • Directors disposed of a combined total of over 19.9 million shares between 6–12 November 2025.
    • Vested performance options for directors and employees were exercised after company stretch revenue targets were reached.
    • A previously announced $7.6 million contract win was withdrawn after it was found to be a revised, not new, order.
    • DroneShield reported shareholder approval for performance options and confirmed compliance with notification and trading policies.
    • The company announced an upcoming increase in its contract materiality disclosure threshold from $5 million to $20 million from 2026.

    What else do investors need to know?

    In November, DroneShield mistakenly announced three standalone contracts valued at $7.6 million as new, when in fact they were reissued due to customer administrative changes. This led to immediate withdrawal and process improvements.

    The company is rolling out new enterprise software systems in January 2026 to improve order processing and reduce manual errors. DroneShield has also engaged external auditors and advisers to review disclosure processes and financial controls.

    Directors’ share sales followed standard company and ASX procedures, with approvals sought and granted, and the resulting disposals promptly disclosed. The directors noted that shares were sold to cover tax liabilities from exercised performance options.

    What’s next for DroneShield?

    DroneShield is working on implementing new ERP and CRM platforms, due to go live in early 2026, which should strengthen operational controls and reporting quality. The business will also update its financial reporting and trading policies based on findings from external reviews.

    Looking ahead, DroneShield plans to increase its order disclosure threshold in line with rising revenue, aiming for clearer reporting and less “noise” from smaller contracts. The company continues to pursue significant contracts in Europe, the US, and Asia-Pacific, although timelines and conversion remain subject to customer processes.

    DroneShield share price snapshot

    DroneShield shares have risen 159% over the past 12 months, outperforming the S&P/ASX 200 Index (ASX: XJO) which has increased 1% over the same period.

    View Original Announcement

    The post DroneShield directors’ share sales and contract error: What investors need to know appeared first on The Motley Fool Australia.

    Should you invest $1,000 in DroneShield Limited right now?

    Before you buy DroneShield Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and DroneShield Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Warren Buffett’s Berkshire Hathaway has increased its exposure to Japanese stocks and here’s why you should too!

    Japan and Australia flags in speech bubbles on black background

    A new report from ASX ETF provider Global X shows there were record-breaking inflows in Japanese stocks in October.

    According to the ETF Market Scoop – October 2025 report, investors poured a record $6 billion into ETFs last month. This surpassed the previous high of $5.8 billion set in July 2025. 

    Total inflows are on track to reach $50 billion in 2025. This is significantly above the $31 billion record in 2024. Ultimately, this year is shaping up to be a record-breaking year for ETFs.

    Interestingly, the report shed light on increased appetite for Japanese securities. 

    Optimism in Japanese stocks

    According to Global X, October 2025 saw an impressive surge of Australian ETF inflows into Japanese equities of $167 million.

    So why invest in Japanese stocks?

    The team at Global X believe the case for investing in Japan is compelling. 

    The report from the ETF provider pointed to a few key catalysts. 

    It said Japanese inflation is normalising, ending decades of deflation and unlocking pricing power, wage growth, and reinvestment. 

    Additionally, sweeping corporate governance reforms driven by the Tokyo Stock Exchange and regulators are prompting companies to repurpose excess cash, increase dividends, and engage in buybacks. 

    Blue-chip firms now boast stronger shareholder-friendly practices and meaningful alignment with global megatrends like AI, EVs, and energy transition.

    In fact, in 2025, the TOPIX index (major index for the Tokyo Stock Exchange) is outperforming the S&P 500 Index (SP: .INX) and the S&P/ASX 200 Index (ASX: XJO). 

    Warren Buffett’s Berkshire Hathaway increases its exposure

    It’s not just ETF investors who are taking notice of the tailwinds for Japanese stocks. 

    Global X said that major investors have also started taking note. Warren Buffett’s Berkshire Hathaway Inc (NYSE: BRK.A) (NYSE: BRK.B) increased its exposure to Japanese companies on the grounds of compelling valuation, strong balance sheets, and efficient capital deployment.

    Taken together, these forces mark Japan’s equity market not as a relic of past stagnation but as a genuine transformation engine – moderate inflation, governance reform, global industrial leverage and renewed investor interest combine into a favourable backdrop.

    How to gain exposure

    For Australian investors seeking exposure to Japanese stocks, there are several ASX ETFs to consider. 

    Firstly, the iShares MSCI Japan ETF (ASX: IJP). 

    The fund is designed to measure the performance of Japanese large & mid-capitalisation companies.

    Secondly, investors could consider the BetaShares Japan ETF – Currency Hedged (ASX: HJPN). 

    The fund aims to track the performance of an index (before fees and expenses) that provides diversified exposure to the largest globally competitive Japanese companies, hedged into Australian dollars.

    Finally, a report from Financial Standard from noted Global X is set to launch its first Japan ETF this month. 

    Unlike other ETFs available right now, it will be the first to track the TOPIX – the Japanese equivalent of the ASX 200.

    According to the report, it will be listed on the ASX under the ticker code of J100.

    The post Warren Buffett’s Berkshire Hathaway has increased its exposure to Japanese stocks and here’s why you should too! appeared first on The Motley Fool Australia.

    Should you invest $1,000 in BetaShares Japan ETF – Currency Hedged right now?

    Before you buy BetaShares Japan ETF – Currency Hedged shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BetaShares Japan ETF – Currency Hedged wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Berkshire Hathaway. The Motley Fool Australia has recommended Berkshire Hathaway. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 3 outstanding ASX growth shares analysts are backing right now

    Happy work colleagues give each other a fist pump.

    The Australian share market is packed with fast-growing companies, which can make choosing the right ones a real challenge. With so many appealing options, narrowing the field becomes essential.

    To help simplify the process, here are three ASX growth shares that analysts are currently positive on and recommending to clients. They are as follows:

    Goodman Group (ASX: GMG)

    Investors don’t normally associate property companies with high growth, yet Goodman Group continues to prove why it’s an exception to the rule.

    Goodman owns, develops, and manages high-specification industrial properties for many of the world’s most influential companies. This includes Amazon, Tesla, and FedEx. These logistics and warehouse facilities sit at the centre of long-term structural trends such as e-commerce, supply chain modernisation, and data-driven distribution.

    The company has also been leaning heavily into data centre development, a sector with enormous demand thanks to artificial intelligence, hyperscale cloud providers, and high-performance computing. This could become a major growth engine for Goodman over the coming decade.

    Morgan Stanley thinks Goodman could be a top ASX growth share to buy. It has an overweight rating and $41.50 price target on its shares.

    Pro Medicus Ltd (ASX: PME)

    Pro Medicus specialises in advanced medical imaging software through its Visage platform, which enables radiologists to review scans with exceptional speed and efficiency. This has made Pro Medicus a preferred partner for some of the leading hospital networks in the United States, where it continues to secure sizeable multi-year contracts.

    What sets the company apart is its combination of growing recurring revenue, world-class margins, and an ultra–capital-light business model, which allows it to convert most of its earnings directly into free cash flow. Few ASX growth shares can match its consistency or profitability profile. And with radiologist shortages expected to continue for some time, its outlook remains very positive.

    The team at Citi recently upgraded Pro Medicus to a buy rating with a $350.00 price target.

    Temple & Webster Group Ltd (ASX: TPW)

    Rounding out the list is Temple & Webster, which is one of Australia’s standout online retail success stories.

    The company has ridden the wave of digital adoption in furniture and homewares, offering shoppers a vast range of stylish and affordable products. Its online-only model gives it structural cost advantages over traditional retailers, helping it take market share even in periods of weaker discretionary spending.

    In addition, Temple & Webster continues to invest in private-label product lines, logistics, and technology to strengthen customer engagement. And, importantly, online penetration in its category remains well below levels seen in comparable markets, meaning the company still has a substantial growth runway ahead of it.

    Macquarie has an outperform rating and $31.30 price target on its shares.

    The post 3 outstanding ASX growth shares analysts are backing right now appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Goodman Group right now?

    Before you buy Goodman Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Goodman Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Goodman Group, Pro Medicus, and Temple & Webster Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon, Goodman Group, Temple & Webster Group, and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended FedEx and Pro Medicus. The Motley Fool Australia has recommended Amazon, Goodman Group, Pro Medicus, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Bell Potter says this ASX 200 share can rise 50%

    A man clenches his fists in excitement as gold coins fall from the sky.

    Nufarm Ltd (ASX: NUF) shares could be an ASX 200 share to buy right now.

    That’s the view of analysts at Bell Potter, which see significant upside potential for the agricultural company’s shares.

    What is the broker saying about this ASX 200 share?

    Bell Potter highlights that Nufarm released its results this week and delivered numbers that were in line with expectations and its guidance. It said:

    Revenue of $3,443m was up +3% YOY (vs. BPe $3,464m). Operating EBITDA of $302.1m was up down -3% YOY (BPe $302.5m and implied guidance of $283-308m). Operating NPAT loss of -$22.9m compares to a -$3.7m loss in FY24 (and vs. BPe -$9.4m). Hybrid Seeds generated EBITDA of $67m (vs. $74m FY24) and the emerging seed platforms incurred a loss of -$53m (-$11m loss in FY24) inclusive of $29m in inventory impairments and ~$20m in operating losses in omega-3.

    It was also pleased to see that Nufarm’s debt had reduced to $824.2 million at the end of FY 2025, which was better than its guidance of $850 million to $925 million.

    Looking ahead, the broker points out that management is guiding to EBITDA growth in FY 2026.

    Key comments: (1) Expect strong FY26e underlying EBITDA growth under normal conditions; (2) Crop protection EBITDA continuing to grow, moderating on the +18% YOY growth in FY25; (2) Seed technologies growth in EBITDA from hybrid Seed and targeting a $30m YOY improvement in the emerging platforms; and (4) Expect positive free cashflow in FY26e and net debt/EBITDA of ~2.0x (vs. 2.7x in FY25).

    Big return potential

    In response to the results, Bell Potter has retained its buy rating on the ASX 200 share with an improved price target of $3.60.

    Based on the current Nufarm share price of $2.37, this implies potential upside of 52% for investors over the next 12 months.

    To put that into context, a $10,000 investment would turn into over $15,000 by this time next year if Bell Potter is on the money with its recommendation.

    In addition, the broker is expecting a modest 1.3% dividend yield in FY 2026, and then 2.1% in FY 2027 and 3% in FY 2028.

    Commenting on its buy recommendation, Bell Potter said:

    NUF delivered a FY25 result modestly ahead of consensus, driven by +170bp topline outperformance in Crop protection revenue growth (relative to sector aggregates) and highlighted by a better-than-expected net debt position. In recent weeks we have witnessed a strengthening in omega-3 oil pricing indicators (following the IMARPE catch quota) while also noting continued YOY growth in active ingredient values.

    The post Bell Potter says this ASX 200 share can rise 50% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Nufarm Limited right now?

    Before you buy Nufarm Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Nufarm Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook

    A group of people in a corporate setting do a collective high five.

    The Sonic Healthcare Ltd (ASX: SHL) share price is in focus after the company reaffirmed its FY26 earnings guidance and posted 8% revenue and EBITDA growth for FY2025.

    What did Sonic Healthcare report in FY25?

    • Statutory revenue for FY2025 rose 8% year-over-year to A$9,645 million
    • EBITDA increased by 8% to A$1,725 million
    • Net profit climbed 7% to A$514 million
    • Earnings per share improved by 6% to 106.7 cents
    • Total FY2025 dividends of $1.07 per share, up 1% on the prior year
    • Cash generated from operations jumped 21% to A$1,297 million

    What else do investors need to know?

    Sonic Healthcare confirmed its FY26 EBITDA guidance range of A$1.87–1.95 billion (on constant currency), targeting up to 13% growth on FY25. Year-to-date statutory revenue as of October 2025 grew 17%, with organic revenue up 5%, supported by recent acquisitions and contract wins.

    The company completed the acquisition of LADR Laboratory Group in Germany, marking a significant milestone. This deal, partly funded by issuing new Sonic shares, is expected to deliver immediate earnings per share accretion and strong returns after synergies.

    What’s next for Sonic Healthcare?

    Looking ahead, Sonic Healthcare expects first-half weighting for FY2026 earnings to follow historical patterns, after an atypical FY2025. The company plans to sustain organic growth through innovation in pathology and diagnostics as well as pursue further targeted acquisitions.

    Management is focused on controlling costs, boosting earnings per share, and extracting value from recent acquisitions, while maintaining a progressive dividend policy supported by ongoing strong cash flows.

    Sonic Healthcare share price snapshot

    Over the past 12 months, Sonic shares have fallen 23%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

    View Original Announcement

    The post Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Sonic Healthcare Limited right now?

    Before you buy Sonic Healthcare Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sonic Healthcare Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Worley holds AGM after growing revenue and maintaining its dividend in FY25

    Happy shareholders clap and smile as they listen to a company earnings report.

    The Worley Ltd (ASX: WOR) share price is in focus today as the company holds its annual general meeting (AGM). In FY25, the global professional services company delivered a steady result, including a 4% uplift in revenue to $12.05 billion and maintaining a 50 cent per share dividend, consistent with previous years.

    What did Worley report in FY25?

    • Aggregated revenue rose 4% to $12,050 million for FY2025
    • Underlying EBITA increased 10% to $823 million
    • EBITA margin (excluding procurement) improved to 9.2%
    • NPATA reached $475 million
    • Normalized cash conversion stood at 94.9%
    • Final dividend maintained at 50 cents per share, unchanged on prior years

    What else do investors need to know?

    Worley’s diversification—with around 50% of revenue from Energy, 24% from Chemicals, and 26% from Resources—helped soften the impact of challenging global conditions. The company continued its disciplined capital management, spending $269 million so far in an on-market share buy-back program of up to $500 million, reflecting ongoing Board confidence in Worley’s financial health.

    Sustainability remained core to Worley’s strategy, with 60% of aggregated FY2025 revenue linked to sustainability-related projects. The business also delivered major projects across LNG, critical minerals, and renewable fuels, and used technology and AI to improve delivery on complex, global contracts. Leadership changes included a new CFO and board renewals to support the company’s next phase of growth.

    What did Worley management say?

    Chris Ashton, CEO and Managing Director said:

    We delivered another strong result in FY2025, in a complex global operating environment marked by economic and political shifts which impacted our customers’ investment decisions. Our result reflects the fourth year of consistent growth in revenue, earnings and margin through the disciplined execution of our strategy.

    What’s next for Worley?

    Looking ahead, Worley expects moderate growth for FY2026, with a focus on higher revenue and underlying EBITA. The company’s earnings are anticipated to be weighted more towards the second half, reflecting seasonality, targeted restructuring, and continued repositioning for areas of high demand and technology-driven growth. Management has revealed plans to unveil a refreshed strategy, targeting new adjacencies and further AI adoption, at its next Investor Day in May 2026.

    Worley says it remains guided by disciplined contract selection, a commitment to sustainability, and ongoing improvement in diversity and inclusion. The leadership team is working to ensure strong foundations for long-term growth while continuing to support customers as the energy, chemicals, and resources landscape evolves.

    Worley share price snapshot

    Over the past 12 months, Worley shares have declined 4%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

    View Original Announcement

    The post Worley holds AGM after growing revenue and maintaining its dividend in FY25 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Worley Limited right now?

    Before you buy Worley Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Worley Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Australian Agricultural Company shrugs off cost-of-living concerns to almost double first-half profit

    Beef cattle in stockyard.

    Beef producer Australian Agricultural Company Ltd (ASX: AAC) has almost doubled its first-half operating profit and says a tightening of beef supply globally could help balance out increased cost-of-living concerns in the second half of the year.

    The company said while there were “unstable market conditions” in the first half, it had executed well across its three strategic focus areas of “better beef, unlocking the value of the land, and partner and invest”.

    Bottom line looking good

    The company’s revenue for the first half was $239.9 million, compared to $195.6 million in the prior corresponding period (pcp). The operating profit came in at $39.8 million, compared to $20.2 million in the pcp.

    The company said in a statement to the ASX that it was a solid result.

    Operating profit, which rose 97% versus the previous corresponding period and is AACo’s highest half year operating profit, was driven by favourable beef and cattle sales margins and supported by a strategic program of earlier live cattle sales compared to the prior period. Good productivity outcomes driven by improved land condition and station-based cattle management activities meant AACo was able to capitalise on increased demand and higher prices for live cattle.

    The company’s average beef price per kilo grew 7% over the previous corresponding period to $18.62 per kilogram, driven by the company’s “sophisticated in-market sales and distribution strategy”.

    Production costs remained steady, down 1% to $2.46 per kilogram.

    AACo managing director David Harris said he was pleased with the progress against the company’s strategy, which was released six months ago.

    There are multiple streams of work underway against those priorities, which will help drive company growth into the future. Our excellent financial results this period further highlight the ability we have to leverage our integrated supply chain to maximise performance. They also demonstrate the different avenues we can take to achieve consistent positive outcomes and create long-term value.   

    Increased investment to drive profits

    AACo said it would continue to invest in its world-class Wagyu herd, which would “improve the genetic profile and overall efficiency of AACo’s herd by increasing the proportion of Wagyu animals, as part of the Better Beef program”.

    That is expected to result in both immediate gains and long-term value creation through improvements in overall quality, and a greater number of animals better suited to the company’s premium brands and high-paying markets.

    The company said it had also progressed its landscape carbon project at Glentana Station in central Queensland with the installation of infrastructure, which would help with the generation of Australian carbon credit units.

    On the outlook, the company said the market remained “dynamic”, with cost-of-living concerns and a downturn in high-end food services being experienced in some key regions.

    The company added:

    However, market reports suggest a tightening of global beef supply could balance out these price pressures, and AACo is well positioned to manage evolving circumstances through its global distribution network.

    AACo did not declare an interim dividend. The company was valued at $867.9 million at the close of trade on Wednesday.

    The post Australian Agricultural Company shrugs off cost-of-living concerns to almost double first-half profit appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Australian Agricultural Company Limited right now?

    Before you buy Australian Agricultural Company Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Australian Agricultural Company Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.